Chenguang Shen

Title: Innovations by Chenguang Shen: A Pioneer in Influenza Research

Introduction

Chenguang Shen is a notable inventor based in Xiamen, China. He has made significant contributions to the field of influenza research, holding a total of 3 patents. His work focuses on developing innovative solutions for the prevention and treatment of influenza virus infections.

Latest Patents

One of Chenguang Shen's latest patents is titled "Mutant of hemagglutinin protein of H3N2 subtype influenza virus and use thereof." This patent discloses a mutant of the hemagglutinin protein of the H3N2 subtype influenza virus, along with its applications. The disclosure also includes a pharmaceutical composition, such as a vaccine, that comprises the mutant, as well as methods for preparing and using the mutant for the prevention and treatment of influenza virus infections.

Another significant patent is "Broad-spectrum monoclonal anti-flu B antibody and uses thereof." This patent provides a broad-spectrum monoclonal anti-Flu B antibody, along with cell strains that generate the antibody. It also details a composition that includes the antibody and its uses for diagnosing, preventing, and treating Flu B infections and related diseases.

Career Highlights

Chenguang Shen is affiliated with Xiamen University, where he conducts his research and development activities. His work has garnered attention in the scientific community, particularly for its potential impact on public health.

Collaborations

Chenguang Shen collaborates with esteemed colleagues, including Yixin Chen and Ningshao Xia, who contribute to his research endeavors.

Conclusion

Chenguang Shen's innovative work in influenza research exemplifies the importance of scientific advancements in combating viral infections. His patents reflect a commitment to improving health outcomes through targeted therapies and preventive measures.